Resolute Holdings Management, Inc. (RHLD) stock intrinsic value fair value estimate & owner earnings analysis

What the business is. Resolute Holdings Management is a seven-person management company. It was spun off from CompoSecure's parent, now called GPGI, on February 28, 2025. It owns no shares in the businesses it runs and earns its money from management fees. Under the CompoSecure Management Agreement (from February 2025) and the Husky Management Agreement (from January 12, 2026, when GPGI completed its roughly $4.976 billion purchase of Husky Technologies), each managed company pays Resolute 2.5% of its trailing twelve-month Adjusted EBITDA every quarter, as the agreements define it. That works out to about 10% of each managed company's EBITDA a year. CompoSecure makes metal payment cards. Its two largest customers, JPMorgan Chase and American Express, were about 55% of its 2025 sales (62% in 2024). Husky, founded in 1953 in Bolton, Ontario, makes injection molding systems, tooling and aftermarket parts and services. Its revenue was $1,517 million in 2023, $1,495 million in 2024 and $1,569 million in 2025. Tooling and aftermarket made up $1,153 million of 2025 revenue and grew every year (about 3.6% a year since 2023). New systems sales are more cyclical: they fell 15% in 2024 before recovering to $416 million in 2025. How we read the accounts. Accounting rules require Resolute to consolidate GPGI Holdings, including Husky, so reported sales, cash flow, debt and net income mostly belong to other shareholders. Reported net income for common stockholders was $61.5 million in the first quarter of 2026 and a $12.4 million loss in the second. Both figures were driven by non-cash tax entries from the consolidation: a $55.8 million benefit and an $18.0 million charge. We ignore these and value only Resolute's own fees, minus its own costs and a 28% tax rate. In 2025, the first, partial year, Resolute earned $12.3 million of fees over ten months against $17.6 million of costs. Those costs included $5.2 million of stock awards paid in GPGI shares. We add that back, because it costs Resolute shareholders nothing. On that basis 2025 was a loss of about $0.8 million, or $0.09 a share. Resolute does not publish a stand-alone cash flow statement, so its owner earnings are built from its segment results. Earning power now. Fees were $12.9 million in the first quarter of 2026 and $13.6 million in the second. Second-quarter fees were $4.7 million from CompoSecure, based on $189.6 million of trailing EBITDA, and $8.9 million from Husky, based on $355.1 million. Resolute's cash operating costs were $8.2 million in the first half. That leaves roughly $27 million a year after tax and before interest, about $3.50 a share. We measure from the Husky agreement onward, because earlier years describe a much smaller business. CompoSecure's trailing EBITDA rose from $161.3 million for 2025 to $189.6 million by June 2026. Our base case starts below today's fee run rate of about $54 million, at $53 million. The contract. Each agreement runs for 10 years and renews automatically for further 10-year terms. A managed company can end it without paying only for serious misconduct, such as a final court judgment that the manager committed a felony. Otherwise it can refuse renewal only at the end of a term, only if two-thirds of its independent directors find the fees unfair, and then it must pay a termination fee. That fee is the greatest of the fees' fair market value, their present value, or four times the fees paid over the prior 24 months, which is about eight years of fees. This protection is why every case carries value beyond year ten. Base case ($46.24 a share). CompoSecure's EBITDA under the agreement starts at $180 million, between 2025's $161 million and the latest $190 million, and grows 3% a year, well below the 10% sales growth it reported for 2025. Husky starts at $350 million and grows 1.5% a year, in line with its 2023 to 2025 revenue record. Resolute's costs start at $17 million and rise 3% a year. Fees rise from $53 million to about $64 million in year ten. Both agreements renew in 2035 to 2036 for a second ten-year term at the year-ten level, after which we count only the termination-fee floor. On these assumptions the business is worth about $443 million. Resolute owes $90.0 million: a $60.0 million term loan taken in May 2026, due three years later and amortizing from September 30, 2026, plus $30.0 million drawn on a $40.0 million revolver that matures in February 2031. Against that it held about $9.9 million of cash, for net debt of about $80 million. That leaves about $363 million, or $46.24 a share on roughly 7.85 million diluted shares. Bear case ($22.39 a share). The JPMorgan Chase and American Express concentration hurts: CompoSecure's EBITDA drops to $150 million and stays there, below its 2025 level. A downturn in Husky's systems sales like 2024's holds Husky at $310 million. Resolute's own costs, which its managers set, start at $19 million and rise 4% a year. Fees stay flat at $46 million and the agreements simply renew with no growth. The business is worth about $256 million, debt is about $80 million net, and the shares are worth about $176 million. The debt stays manageable: yearly cash of $14 to $21 million comfortably covers about $6 million of interest. Bull case ($69.31 a share). CompoSecure grows 6% a year from $188 million and Husky grows 3% a year from $355 million, in line with its aftermarket record. Costs start at $16.5 million, and the agreements keep renewing at the year-ten level. The business is worth about $624 million, debt is about $80 million net, and the shares are worth about $544 million. What is left out, and what could prove us wrong. Resolute's stated plan is for the companies it manages to buy more businesses. Each purchase adds fee income without Resolute putting up any capital. So far there has been one such deal, Husky, which is not yet a repeatable record, so no case gives credit for future acquisitions. A steady run of well-priced acquisitions is the main way the shares could be worth more than our figures. On the other side, Husky added heavy borrowing at the managed level: about $2.1 billion at GPGI Holdings, including a $1.2 billion term loan and $900 million of 5.625% notes due 2033. That debt is not owed by Resolute, but stress at GPGI would put the fee stream at risk. Resolute also borrowed to buy back 671,552 of its own shares for $87.5 million in the first half of 2026. That is about $130 a share, well above our base value, so on our numbers those purchases reduced per-share value. Finally, Resolute's managers decide which costs Resolute bears and which GPGI reimburses.